期刊文献+

Clinical features and treatment strategies for older prostate cancer patients with bone metastasis 被引量:6

老年前列腺癌伴骨转移患者的临床特征及治疗策略
下载PDF
导出
摘要 To identify the clinical features and independent predictors of survival in older patients with bone metastasis from prostate cancer (PCa). We retrospectively analysed 205 older patients with bone metastases from PCa between 1997 and 2012. The Kaplan-Meier method was used with the log.rank test for survival rate calculations and to evaluate each variable. Multivariate analysis was performed with the Cox regression model. The chi-squared test was used to compare survival rates between older and younger (n= 197) patients. All patients were followed up. The 1-, 2-, 3- and 5-year survival rates were 95.5%, 77.5%, 68.5% and 33.7%, respectively. Gleason score, radiotherapy of the primary tumour, the number of bone metastases, the alkaline phosphatase alkaline phosphatase (ALP) level, organ metastasis and regional lymph node metastasis were associated with the survival rates. Multivariate Cox regression analysis showed that Gleason score at diagnosis of the primary tumour was a significant predictor of overall survival following the diagnosis of bone metastases. In addition, the overall survival rates of older patients were higher compared with younger patients, but older patients who underwent radiotherapy had higher mortality. These data may serve as a guide for creating clinical prediction models in further studies. To identify the clinical features and independent predictors of survival in older patients with bone metastasis from prostate cancer (PCa). We retrospectively analysed 205 older patients with bone metastases from PCa between 1997 and 2012. The Kaplan-Meier method was used with the log.rank test for survival rate calculations and to evaluate each variable. Multivariate analysis was performed with the Cox regression model. The chi-squared test was used to compare survival rates between older and younger (n= 197) patients. All patients were followed up. The 1-, 2-, 3- and 5-year survival rates were 95.5%, 77.5%, 68.5% and 33.7%, respectively. Gleason score, radiotherapy of the primary tumour, the number of bone metastases, the alkaline phosphatase alkaline phosphatase (ALP) level, organ metastasis and regional lymph node metastasis were associated with the survival rates. Multivariate Cox regression analysis showed that Gleason score at diagnosis of the primary tumour was a significant predictor of overall survival following the diagnosis of bone metastases. In addition, the overall survival rates of older patients were higher compared with younger patients, but older patients who underwent radiotherapy had higher mortality. These data may serve as a guide for creating clinical prediction models in further studies.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2013年第6期759-763,I0006,I0007,共7页 亚洲男性学杂志(英文版)
关键词 bone metastasis OLDER prognostic analysis prostate cancer (PCa) clinical feature bone metastasis older prognostic analysis prostate cancer (PCa) clinical feature
  • 相关文献

参考文献1

二级参考文献25

  • 1Dallari R, Gazzotti GL, Barozzini P, Cervi F, Cavani R. [Bone metastases as a sign ofthe existence of latent neoplasia]. Minerva Med 1986; 77: 981-7. Italian.
  • 2DragoJR. Diagnostic techniques in prostatic cancer. Post grad Med1986; 80: 214-7.
  • 3Buhmeida A, Pyrhonen S, Laato M, Collan Y. Prognostic factors in prostate cancer. Diagn Pathol2006; 3: 4.
  • 4SteuberT, O'Brien MF, Lilja H. Serum markers for prostate cancer: a rational approach to the literature. Eur Urol2008; 54: 31-40.
  • 5Shariat SF, Semjonow A, Lilja H, Savage C, Vickers AJ et al. Tumor markers in prostate cancer I: blood-based markers. Acta Oncol2011; 50 Suppll: 61-75.
  • 6Kageyama Y, Kihara K, Kamata S, Nagahama K, Yonese Jet al. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastases in prostate cancer]. Hinyokika Kiyo 1996; 42: 197-9. Japanese.
  • 7Xu J, Wang R, Xie ZH, Odero-Marah V, Pathak Setal. Prostate cancer metastases: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastases. Prostate 2006; 66: 1664-73.
  • 8Imai K, Suzuki T, Shimizu T, Yamanaka H, Kanetake H et al. Analysis of survival of prostate cancer patients in Japan and the U.S.A. Adv Exp Med Biol 1992; 324: 29-38.
  • 9Reddi AH, Roodman D, Freeman C, Mohla S. Mechanisms of tumor metastases to the bone: challenges and opportunities. J Bone Miner Res 2003; 18: 190-4.
  • 10Conti G, La Torre G, Cicalese V, Micheletti G, Ludovico MG et al. Prostate cancer metastases to bone: observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline features. Arch ltal Urol Androl2008; 80: 59-64.

共引文献14

同被引文献20

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部